"Uremia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Descriptor ID |
D014511
|
| MeSH Number(s) |
C12.777.419.936 C13.351.968.419.936
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Uremia".
Below are MeSH descriptors whose meaning is more specific than "Uremia".
This graph shows the total number of publications written about "Uremia" by people in this website by year, and whether "Uremia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Uremia" by people in Profiles.
-
Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD. J Am Soc Nephrol. 2021 11; 32(11):2834-2850.
-
The young, the uremic and the broken. Nephrol Dial Transplant. 2020 10 01; 35(10):1649-1651.
-
Novel dietary and pharmacologic approaches for acid-base modulation to preserve kidney function and manage uremia. Curr Opin Nephrol Hypertens. 2020 01; 29(1):39-48.
-
Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease. Kidney Int. 2020 03; 97(3):538-550.
-
Histopathological and proteomic analyses identify integrin-?1 as a potential mediator of phlebosclerosis in uremic patients. Clin Exp Nephrol. 2019 Sep; 23(9):1100-1108.
-
Uremia: A historical reappraisal of what happened?. Clin Nephrol. 2018 May; 89(5):305-313.
-
Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans. J Am Soc Nephrol. 2018 03; 29(3):1063-1072.
-
Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk. Sci Transl Med. 2017 Nov 22; 9(417).
-
A History of Uremia Research. J Ren Nutr. 2017 11; 27(6):449-452.
-
Platelet aggregometry cannot identify uremic platelet dysfunction in heart failure patients prior to cardiac surgery. J Clin Lab Anal. 2017 Sep; 31(5).